Treatment of any disease requires considerable expenses. Timely revelation of latent sicknesses helps to cure them with minimum expenditures and also preventing transformation of diseases into a chronic phase.

According to a group of authors (including Y. Mostovoy, Y. Babiychuk, O. Petrenko, D. Mostovaya, 2002), estimation of financial losses associated with getting sick is the following:

- direct expenses (hospital or polyclinic treatment cost, purchasing medications, emergency medical aid, etc), which are largely paid by a patient or his or her family;

- indirect expenses (lowering of labor productivity, losses of working and learning days, social expenditures) are paid by a patient, his or her family and state,

- immeasurable expenses (monetary evaluation of quality of life).

Indirect state and company’s expenses are basically composed of the following indicators:

- paying for disability days

- unpaid taxed

- providing disability pension

- providing work disability benefits

- industrial losses

Indirect losses increase in direct dependency of the number of disabled patients.

Immeasurable expenses or evaluation of quality of life is the difference between overall sickness expenses and charges for medical treatment and diagnostics, which did not yield an expected efficiency.

Treatment of any sickness is associated with significant financial expenses. Therefore early disease detection and prevention is much more effective than its treatment.

As an example, let’s briefly examine Diabetes mellitus, widely spread disease detected in all age groups. Sadly enough, it cannot be cured and causes a lot of suffering. At the time, approximately 150 million people worldwide are suffering from diabetes, out of this number 90% are suffering from insulin-independent (type II) diabetes. Taking in account the society’s ageing and further urbanization, the World Health Organization forecasts the growth of diabetes up to 333 million people in 2025. Especially significant growth will be observed in economically developing countries. The world’s adult population is blighted by an evident diabetes epidemic. This trend is correlated with changes in the ways of living, social and economic transformations.

Diabetes is a sickness which imposes a predetermined way of living. Diabetes implements certain precautions for preventing heavy further worsening of life quality and can even result in death. Micro and macroangiopathy may result in so-called diabetes foot with trophic ulcers and gangrene, retinopathy and blindness, nephropathy and chronic renal insufficiency, elevated risk of infarction and stroke, immunodeficiency, which, in turn, leads to increased risk of infection and oncology diseases. As estimated by Russian experts, more than 60% of all expenses associated with diabetes are indented for treatment of diabetes’ complications. Consequently, by reducing diabetes occurrence, long-term effect for diabetes patients and society in general will be achieved. Insufficient glycemia monitoring results in vascular diabetes complications which, similar to the II type diabetes (i.e. insulin-independent diabetes arising in aged people), may proceed without clinical symptoms. Due to its slow evolution and sub-clinic development, forecasting, proactive countermeasures and treatment of this sickness are not quite efficient.  Because of insufficient availability of equipment  for early detection and monitoring of diseases, the angiopathy incidence, reported by district physicians, is underestimated by 3-4 times (W. Fabian, L. Majkowska, A. Stefanski, P. Moleda, 2008). Every 30 seconds diabetes-induced lower limb amputation takes place. Furthermore, only after this surgery a patient comes to know that he is suffering from diabetes. It should be mentioned, however, that 85% of these amputations can be avoided if the correct medical assistance and sufficient level of awareness of population on diabetes complications can be provided.

During the CODE-2 research, it was established that the presence of micro and macroangiopathy increases treatment of II type diabetes by 2,5 times in comparison with patients without complications. Similar research implemented in Germany demonstrated that foot ulcer and stroke increase treatment cost by 4 times, and risk of amputation by 6 times. Insulin-dependent patients need enhanced and improved early detection of diabetes’ complications as the majority of them are suffering from hypertension (more than 80% cases) and dyslipidemia. Because of difficulty to adequately control glycemia, normalize lipid composition and the arterial pressure in the majority of cases, the risk for worsening of microangiopathy complications is really high.

“СЕМ^® ThermoDiagnostics” personal thermograph helps to find out blood circulation disturbances of feet and brain at early pre-clinic stages. This helps doctors timely prescribe proactive countermeasures and prevent worsening of highly detrimental complications. At the same time, thermal control of the effectiveness of the implemented treatment of micro- and macro-angiopathy becomes possible.

Treatment of various acute diseases, the most frequent of which are acute respiratory virus infection and influenza, also requires sizeable direct and indirect financial expenses. For example, the initial set of influenza drugs for an adult patient is comparable with a minimum monthly wage. Complete course of treatment may require further additional drugs and preventive actions.    Furthermore, treatment of children is even more expensive even in case of lack of complications. In case of complications, antibiotics therapy and, sometimes, even hospitalization become necessary. Treatment with antibiotics may give side effects, including allergic reactions, immunodeficiency, dysbacteriosis, toxic organ damages, etc., which, in turn, also need to be cured.

CEM^® ThermoDiagnostics personal thermograph helps to detect and timely cure immunodeficiency, which lowers respiratory and other disease occurrence. Due to the above, we would recommend all companies to have СЕМ^® ThermoDiagnostics preventive personal thermograph for timely detection employees’ immunodeficiency.

Treatment of any diseases requires tangible financial expenses. Timely detection of an acute sickness allows treating it with minimum expenses and preventing it from transition into a chronic phase. Chronic diseases last long periods and complete healing from them is not always possible, only so called stable remission could be achieved. CEM^® ThermoDiagnostics personal thermograph allows to detect thermal characteristics of acute diseases, preventing its transformation into a chronic phase and, consequently, saving all types of treatment expenses, avoiding hospitalization and visits to out-patient clinics, shortening treatment time and so forth.

CEM^® ThermoDiagnostics enables broadening diagnostics capabilities for doctors of different specializations. Furthermore, СЕМ^®-Thermography software program allows visualization of problematic parts of a human body for physicians, cosmetologists, massagers, patients themselves and help them select the best treatment method on an individual basis (i.e. a drug, physiotherapeutic method, biologically active food additives and so forth). It also helps to check body’s reaction on treatments and other impacts.

CEM^® ThermoDiagnostics enables to perform self-examinations, detect serious latent diseases at very early stages and schedule doctor’s appointment timely. Therefore, the use of CEM^® ThermoDiagnostics personal thermograph helps to increase life length and improve its quality, save your energy, time and money. The earlier the treatment starts, the higher its effectiveness.

In addition to all the above, consumption of food and beverages of correct temperature, detection and elimination of heat leakages from your house improves quality of living and helps to prevent diseases.

Therefore, the use of CEM^® ThermoDiagnostics is beneficial to EVERYBODY:

1.  to all people for extending life span and improving quality of life;

2. to professionals (physicians, cosmetologists, massagers, coaches, massagers) as inexpensive, simple and visual instrument for thermal diagnostics and monitoring of treatment’s efficiency;

3. to manufacturers and distributors of instruments for physiotherapeutic treatment, distributors of biologically active food additives and similar products for substantiating and controlling their efficiency;

4. to employers for decreasing sickness incidence and all associated losses;

5. to the state, as it helps decreasing sickness incidence and incapacitation of its citizens.

We are confident that EVERYBODY needs СЕМ^®!!!